Louisiana State Employees Retirement System’s Albany Molecular Research Inc AMRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-12,000
Closed -$161K 1449
2016
Q2
$161K Buy
12,000
+100
+0.8% +$1.46K 0.01% 1398
2016
Q1
$182K Hold
11,900
0.01% 1373
2015
Q4
$236K Hold
11,900
0.01% 1328
2015
Q3
$207K Buy
11,900
+1,200
+11% +$24.4K 0.01% 1356
2015
Q2
$216K Buy
10,700
+300
+3% +$5.79K 0.01% 1387
2015
Q1
$183K Sell
10,400
-100
-1% -$1.7K 0.01% 1411
2014
Q4
$171K Sell
10,500
-400
-4% -$7.34K 0.01% 1425
2014
Q3
$241K Buy
+10,900
New +$223K 0.01% 1363

Other funds holding AMRI

Louisiana State Employees Retirement System's AMRI Position: Q3 2016 in Review

Louisiana State Employees Retirement System sold out of Albany Molecular Research Inc (AMRI) in Q3 2016, closing a stake of 12,000 shares — an estimated $161K sold.

Louisiana State Employees Retirement System first reported a position in AMRI in Q3 2014 and held it in 8 quarters. The position peaked at $241K in Q3 2014. 137 funds tracked by Wall St. Rank hold AMRI as of Q3 2016.

  • Louisiana State Employees Retirement System reported no remaining Albany Molecular Research Inc position as of Q3 2016 after selling out during the quarter.
  • Louisiana State Employees Retirement System sold 12,000 Albany Molecular Research Inc shares in Q3 2016, an estimated $161K.
  • Louisiana State Employees Retirement System first reported a position in Albany Molecular Research Inc in Q3 2014 and held it in 8 quarters.
  • Louisiana State Employees Retirement System's Albany Molecular Research Inc position peaked at $241K in Q3 2014.
  • 137 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2016.

Based on Louisiana State Employees Retirement System's 13F filing for Q3 2016, filed 25 Oct 2016.